News Release

ARRS Annual Meeting: vascularity, elastography in suspicious TIRADS scores differentiate malignant thyroid nodules

Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting determined that assessing the vascularity and elastography in suspect TIRADS categories can efficiently diagnose malignancy of thyroid nodules

Reports and Proceedings

American Roentgen Ray Society

Gray-scale features of markedly hypoechoic thyroid nodule with irregular margin (TIRADS-4), confirmed as papillary thyroid carcinoma

image: A. Elastography shows mostly blue pattern; B. Doppler sonography shows no flow pattern. view more 

Credit: ARRS

Honolulu, HI | April 18, 2023—Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting on the island of Oahu determined that assessing the vascularity and elastography in suspect TIRADS categories can efficiently diagnose malignancy of thyroid nodules.

Acknowledging that sonographic TIRADS scoring remains the first method of imaging assessment for diagnosing malignant thyroid nodules, “we assessed the added value of shear-wave elastography (SWE) to classic TIRADS assessment,” said Leila Aghaghazvini, MD, from the department of radiology at Shariati Hospital and Iran’s University of Medical Sciences in Tehran.

In this ARRS Annual Meeting Cum Laude award-winning Online Poster, 200 total thyroid nodules were assessed by conventional sonography to ascertain TIRADS score and pertinent descriptors. Using a 7.5 MHz probe to asses vascularity pattern and resistive index (RI), elastography evaluations were performed quantitatively via color mapping and calculating mean and maximum velocities in shear-wave modality. Final diagnoses of all thyroid nodules were confirmed by histopathology assessment or follow-up imaging.

According to Aghaghazvini et al., patient mean age was 53 years; 105 were men [52.5%]. And of 27 [13.5%] total nodules with malignancy in their study, 14 [7%] were papillary thyroid carcinoma, 11 [5.5%] were follicular thyroid carcinoma, and 2 [1%] were medullary thyroid cancer. AUC of the ROC curve for TIRADS assessment was 0.76. Results found 37 [18.5%] TIRADS 4 nodules, wherein 15 [40.5%] were malignant, and 57 [28.5%] TIRADS 5 nodules, 12 [21.1%] of which were malignant.

In only TIRADS 4 nodules, Doppler grade AUC, RI, color map elastography grade, SWE maximum velocity, and mean SWE velocity for diagnosing malignancy were 0.8, 0.93, 0.89, 0.86, and 0.82, respectively. Meanwhile, profiles in TIRADS 5-only nodules were 0.8, 0.96, 0.85, 0.96, and 0.97, respectively. Additionally, in TIRADS 4, an RI cutoff point of 0.6 yielded diagnostic efficacy indices of 0.93, 1, 0.97, 1, and 0.96 for sensitivity, specificity, efficiency, PPV and NPV, respectively. In TIRADS 5 nodules, a cutoff point of 4.33 for SWE mean velocity yielded diagnostic efficacy indices of 1, 0.82, 0.86, 0.6, and 1 for sensitivity, specificity, efficiency, PPV and NPV, respectively.


North America’s first radiological society, the American Roentgen Ray Society (ARRS) remains dedicated to the advancement of medicine through the profession of medical imaging and its allied sciences. An international forum for progress in radiology since the discovery of the x-ray, ARRS maintains its mission of improving health through a community committed to advancing knowledge and skills with the world’s longest continuously published radiology journal—American Journal of Roentgenology—the ARRS Annual Meeting, InPractice magazine, topical symposia, myriad multimedia educational materials, as well as awarding scholarships via The Roentgen Fund®.

MEDIA CONTACT:

Logan K. Young, PIO

44211 Slatestone Court

Leesburg, VA 20176

lyoung@arrs.org


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.